ChromaDex Corporation
NASDAQ:CDXC
Overview | Financials
| Company Name | ChromaDex Corporation |
| Symbol | CDXC |
| Currency | USD |
| Price | 7.87 |
| Market Cap | 611,895,648 |
| Dividend Yield | 0% |
| 52-week-range | 2.305 - 9.18 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Mr. Robert N. Fried |
| Website | https://www.chromadex.com |
An error occurred while fetching data.
About ChromaDex Corporation
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD





